Concepedia

Xueyan Liao

XL

12

Publications

319

Citations

11

H-Index

2004

Active since

Affiliations

Guangxi Center for Disease Prevention and Control(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

National Institutes for Food and Drug Control

Peking University

Chinese Academy of Medical Sciences & Peking Union Medical College

Xueyan Liao is an author at Guangxi Center for Disease Prevention and Control specializing in medicine, vaccination, and vaccine safety.

Top concepts

Publications per year

2004–2022

12

Publications

12

Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up

Lihui Wei, Xing Xie, Jihong Liu et al. · Vaccine · 2018 · 53 citations

, , +9

Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial

Zhaojun Mo, Mo Yi, Mingqiang Li et al. · Vaccine · 2017 · 50 citations

, , +8

Human rotavirus vaccine (RIX4414) efficacy in the first two years of life

Rongcheng Li, Teng Huang, Yanping Li et al. · Human Vaccines & Immunotherapeutics · 2013 · 43 citations · Full text

Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up

Wen Chen, Yun Zhao, Xing Xie et al. · Vaccine · 2019 · 36 citations

, , +10

Dynamic change of mother-source neutralizing antibodies against enterovirus 71 and coxsackievirus A16 in infants

Qunying Mao, Xueyan Liao, Yu Xiang et al. · Chinese Medical Journal · 2010 · 28 citations · Full text

Rows per page

1–5 of 12